Remedium Capital Partners as of June 30, 2026
Portfolio Holdings for Remedium Capital Partners
Remedium Capital Partners holds 6 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Oruka Therapeutics (ORKA) | 33.0 | $149M | 1.6M | 95.17 | |
| Aeglea Biotherapeutics (SYRE) | 28.8 | $130M | 1.5M | 88.78 | |
| Apogee Therapeutics (APGE) | 17.2 | $78M | 587k | 132.73 | |
| Galecto (DMRA) | 11.8 | $53M | 2.0M | 26.01 | |
| Jade Biosciences (JBIO) | 7.8 | $35M | 1.6M | 22.22 | |
| Crescent Biopharma (CBIO) | 1.4 | $6.5M | 361k | 18.00 |
